Intravenous Ibandronate in the Treatment of Osteoporosis: A Viewpoint by Jean-Yves Reginster

ISSN： 0012-6667

Source： Drugs, Vol.66, Iss.12, 2006-01, pp. : 1602-1603

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravenous Ibandronate: In the Treatment of Osteoporosis

By Croom Katherine F. Scott Lesley J.

Drugs, Vol. 66, Iss. 12, 2006-01 ,pp. : 1593-1601

Adis International

Access to resources Recommend Favorite

Intravenous Ibandronate in the Treatment of Osteoporosis: Profile Report

By Croom Katherine F. Scott Lesley J.

Drugs & Aging, Vol. 23, Iss. 12, 2006-01 ,pp. : 997-1001

Adis International

Access to resources Recommend Favorite

Review of ibandronate in the treatment of osteoporosis

By Chapurlat Roland D Delmas Pierre D

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 3, 2003-03 ,pp. : 391-396

Informa Healthcare

Access to resources Recommend Favorite

Oral and Intravenous Ibandronate in the Management of Postmenopausal Osteoporosis: A Comprehensive Review

Current Pharmaceutical Design, Vol. 11, Iss. 28, 2005-11 ,pp. : 3711-3728

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Utility of a Pharmacostatistical Model for Ibandronate in Postmenopausal Osteoporosis

Current Drug Metabolism, Vol. 7, Iss. 7, 2006-10 ,pp. : 827-836

Bentham Science Publishers

Access to resources Recommend Favorite